XML 13 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development (including related party amounts of $72 and $228, respectively) $ 14,379 $ 15,377
General and administrative (including related party amounts of $85 and $134, respectively) 5,327 5,041
Total operating expenses 19,706 20,418
Loss from operations (19,706) (20,418)
Interest income 2,070 2,703
Net loss $ (17,636) $ (17,715)
Net loss per share, basic $ (0.29) $ (0.31)
Net loss per share, diluted $ (0.29) $ (0.31)
Weighted-average shares of common stock outstanding, basic 61,434,457 56,757,827
Weighted-average shares of common stock outstanding, diluted 61,434,457 56,757,827